Clinical Trial Update: Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether genetic testing can predict response to paclitaxel in women with breast cancer; the study was terminated with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Georgetown University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-11